<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04105660</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00132</org_study_id>
    <nct_id>NCT04105660</nct_id>
  </id_info>
  <brief_title>Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)</brief_title>
  <official_title>Recovery From Propofol Anaesthesia Guided by Frontal EEG Wave Analysis Compared to Bispectral Index Monitoring Alone in Laparoscopic Surgery: A Multicentre Double-blind Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cantonal Hospital of Graubünden, Chur, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical
      parameters to assess the depth of anaesthesia during general anaesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical
      parameters to assess the depth of anaesthesia during general anaesthesia. In addition to the
      bispectral (BIS) index displayed as an index, the raw frontal EEG can be displayed as a curve
      on these monitors. After a short training, anaesthetists might be more accurate and faster in
      assessing depth of anaesthesia by recognizing the pattern of the EEG curve than by using the
      BIS index. This may further enhance the positive effects that could be demonstrated for the
      use of BIS monitors.

      Therefore, the aim of the investigator's study is to investigate the clinical relevance of
      interpreting the raw frontal EEG in addition to only using the BIS index for titrating
      intravenous anaesthetics.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery (QoR): QoR-15 scale</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol consumption</measure>
    <time_frame>during anaesthesia</time_frame>
    <description>Propofol consumption in mg/kg/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery (QoR): QoR-15 scale</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in postanaesthesia care unit (PACU)</measure>
    <time_frame>At arrival to and at discharge from postanaesthesia care unit (an average of 120 minutes)</time_frame>
    <description>Time in minutes from arrival in PACU until discharge from PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>At time of skin closure and at time of extubation (an average of 90 minutes)</time_frame>
    <description>Time in minutes from skin closure to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of awareness</measure>
    <time_frame>daily from admission up to hospital discharge, an average of approximately 14 days</time_frame>
    <description>Brice interview daily until hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldrete score</measure>
    <time_frame>Once at discharge from postanaesthesia care unit (PACU), approximately on day 2 of admission to hospital</time_frame>
    <description>Measurement of recovery; score is 0 to 10, 0 means worst recovery, 10 means best recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Postoperative Nausea and Vomiting (PONV)</measure>
    <time_frame>daily from admission up to hospital discharge, an average of approximately 14 days</time_frame>
    <description>Incidence of nausea and vomiting daily until hospital discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Intervention arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG monitoring in addition to standard monitoring (clinical parameters and BIS index)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard monitoring including clinical parameters and BIS index</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training for EEG monitoring</intervention_name>
    <description>Training for reading EEG curves during anaesthesia</description>
    <arm_group_label>Intervention arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard monitoring</intervention_name>
    <description>Standard monitoring including clinical parameters and BIS index</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Intervention arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients undergoing in-hospital laparoscopic abdominal surgery with general
             anaesthesia using Propofol based on the Schnider model (target controlled infusion)42,
             43

          -  Minimal duration of surgery of 60 minutes

          -  Written informed consent

        Exclusion Criteria:

          -  Same-day surgery

          -  Language barrier

          -  Patients under 18 years of age

          -  Pregnancy (using a beta-human chorionic gonadotropin (HCG) measurement in a blood
             sample of women in childbearing age)

          -  Allergy to Propofol

          -  Administration of hypnotics other than Propofol, such as ketamine or midazolam
             preoperatively or intraoperatively

          -  Known brain pathology, such as seizure disorders, dementia, cerebrovascular disease or
             brain death
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salome Dell-Kuster, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph S Burkhart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital Graubünden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salome Dell-Kuster, MD MSc</last_name>
    <phone>+41613286474</phone>
    <email>salome.dell-kuster@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph S Burkhart, MD</last_name>
    <email>christoph.burkhart@ksgr.ch</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

